Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEIG family member 2 (abbreviated as EEIG2, also called FAM102B and several other aliases) is a protein-coding gene in humans[6][2]. It is orthologous to mouse Eeig2, which is expressed in the nervous system[4]. EEIG2 is associated with autism spectrum disorder, but its precise biological function, protein structure, and pathways remain poorly defined based on current publicly available sources[2][6]. There is no evidence that EEIG2 is a direct drug target, a receptor, enzyme, transporter, channel, or transcription factor; instead, it is a less-well-characterized protein whose paralog is EEIG1[2]. No known drugs target EEIG2, and there are no established mechanisms of drug action or biomarkers linked to this gene. The gene's sequence, paralogy, and some disease involvement (autism) are cataloged, but functional annotation and therapeutic relevance remain unclear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EEIG family member 2 (EEIG2).